Centre Hospitalier Universitaire Reims

At Centre Hospitalier Universitaire Reims, the Chirurgie pédiatrique department is involved in clinical research focused on congenital, hereditary, and neonatal diseases, with attention to conditions affecting children and newborns. Studies in this area explore better diagnosis, safer surgical decision-making, and improved treatment pathways for complex pediatric disorders.

• Research on adnexal torsion to improve diagnosis and avoid unnecessary surgery
• Studies in Hirschsprung’s disease and other congenital digestive conditions
• Trials addressing posterior urethral valves and pediatric urinary tract disease
• Work on rare pediatric tumors such as neuroblastoma, retinoblastoma, and hepatoblastoma

This research reflects a strong pediatric focus on improving outcomes for children with structural abnormalities, rare cancers, and surgically relevant conditions.

The site shows major activity in hematology and onco-hematology, with trials spanning leukemia, lymphoma, and related blood disorders. Many studies aim to refine treatment strategies, improve survival, and reduce relapse risk in both adults and children.

• Studies in acute lymphoblastic leukemia for children, adolescents, and young adults
• Research in acute myeloid leukemia, chronic lymphocytic leukemia, and myelodysplastic syndromes
• Trials for multiple myeloma, mantle-cell lymphoma, and follicular lymphoma
• Work on improving outcomes in peripheral T-cell lymphoma and other rare hematologic cancers

These studies focus on testing new treatment approaches, optimizing existing therapies, and supporting longer-term disease control in Centre Hospitalier Universitaire Reims.

A large share of the clinical research portfolio covers digestive system diseases and gastrointestinal cancers. Trials in this field examine ways to improve surgery, systemic treatment, and postoperative care for cancers of the stomach, colon, rectum, pancreas, biliary tract, and esophagus.

• Studies in colorectal cancer, including metastatic and locally advanced disease
• Research on gastric cancer, gastroesophageal junction adenocarcinoma, and esophageal cancer
• Trials for pancreatic adenocarcinoma, biliary cancer, and hepatocellular carcinoma
• Work on gastrointestinal stromal tumor and neuroendocrine tumors

The main goal is to evaluate better treatment effectiveness, support personalized care, and improve outcomes after surgery or during advanced disease management.

The site also conducts research in immune system diseases and rheumatology, including chronic inflammatory conditions that can affect joints, muscles, blood vessels, and connective tissue. These trials often aim to control disease activity, reduce flares, and improve quality of life.

• Studies in rheumatoid arthritis, psoriatic arthritis, and polymyalgia rheumatica
• Research on giant cell arteritis, vasculitis, and systemic sclerosis
• Trials for dermatomyositis, polymyositis, and inclusion body myositis
• Work on skin and immune disorders such as pemphigus and mucous membrane pemphigoid

This area of research focuses on testing new therapies and improving long-term disease control for patients with complex autoimmune conditions.

Clinical trials at the site also cover respiratory tract diseases, kidney disease, and cardiovascular disease. These studies address common and serious conditions such as heart failure, chronic kidney disease, asthma, pulmonary fibrosis, and stroke, with an emphasis on better prevention and treatment effectiveness.

• Studies in heart failure, atherosclerotic cardiovascular disease, and stroke
• Research on chronic kidney disease, kidney transplantation, and transplant-related infection prevention
• Trials for asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis
• Work on pulmonary arterial hypertension and other serious lung conditions

These investigations aim to improve symptom control, reduce complications, and support better long-term outcomes across major chronic diseases.

The research portfolio includes nervous system diseases, virus diseases, and other specialized areas where new diagnostic or therapeutic approaches are needed. Trials here often focus on rare, severe, or hard-to-treat conditions.

• Studies in diffuse intrinsic pontine glioma, ependymoma, and mild cognitive impairment
• Research on sepsis, Clostridioides difficile infection, and chronic pulmonary aspergillosis
• Trials for HIV, HPV-related disease, and transplant-related viral complications
• Work on rare metabolic and hematologic disorders, including immune thrombocytopenia and autoimmune hemolytic anemia

This mix of studies shows a broad commitment to advancing care for uncommon and high-risk diseases through improved diagnostics and treatment evaluation.